CI
ZBH icon

CX Institutional’s Zimmer Biomet ZBH Stock Holding History

CX Institutional’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$258K Buy
2,999
+1,825
+155% +$160K 0.01% 680
2026
Q1 		$106K Sell
1,174
-910
-44% -$83.5K ﹤0.01% 844
2025
Q4 		$187K Buy
2,084
+570
+38% +$54K 0.01% 735
2025
Q3 		$149K Buy
1,514
+354
+31% +$35.1K ﹤0.01% 763
2025
Q2 		$106K Sell
1,160
-1,350
-54% -$131K ﹤0.01% 758
2025
Q1 		$284K Buy
2,510
+174
+7% +$18.6K 0.01% 495
2024
Q4 		$247K Buy
2,336
+1,477
+172% +$158K 0.01% 475
2024
Q3 		$92.7K Buy
+859
New +$93.7K ﹤0.01% 550
2024
Q2 		– Sell
-2,109
Closed -$278K – 571
2024
Q1 		$278K Buy
2,109
+119
+6% +$14.9K 0.01% 476
2023
Q4 		$242K Buy
+1,990
New +$222K 0.01% 452
2023
Q3 		– Sell
-1,622
Closed -$236K – 560
2023
Q2 		$236K Buy
+1,622
New +$220K 0.01% 474
2022
Q3 		– Sell
-747
Closed -$79K – 1149
2022
Q2 		$79K Buy
+747
New +$88.6K 0.01% 590
2021
Q4 		– Sell
-473
Closed -$67K – 923
2021
Q3 		$67K Buy
473
+105
+29% +$15.4K 0.01% 529
2021
Q2 		$57K Buy
368
+81
+28% +$13.1K ﹤0.01% 543
2021
Q1 		$45K Buy
287
+57
+25% +$8.83K ﹤0.01% 513
2020
Q4 		$34K Buy
230
+112
+95% +$15.8K ﹤0.01% 508
2020
Q3 		$16K Buy
118
+15
+15% +$1.96K ﹤0.01% 598
2020
Q2 		$12K Buy
103
+75
+268% +$8.64K ﹤0.01% 539
2020
Q1 		$3K Sell
28
-28
-50% -$3.67K ﹤0.01% 641
2019
Q4 		$8K Hold
56
– – ﹤0.01% 479
2019
Q3 		$7K Buy
56
+10
+22% +$1.29K ﹤0.01% 527
2019
Q2 		$5K Sell
46
-1
-2% -$117 ﹤0.01% 626
2019
Q1 		$6K Buy
+47
New +$5.34K ﹤0.01% 531

Other funds holding ZBH

DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
WAM
Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return
QAM
QSM Asset Management London, United Kingdom $193M AUM 47.49% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
NCM
Northside Capital Management Hood River, Oregon $1.22B AUM 20.77% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
GHAM
Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CX Institutional's ZBH Position: Q2 2026 in Review

CX Institutional increased its Zimmer Biomet (ZBH) stake by 155% in Q2 2026, buying an estimated $160K and bringing the position to 2,999 shares worth $258K. The position accounts for 0.01% of the portfolio, ranked #680.

CX Institutional first reported a position in ZBH in Q1 2019 and has held it in 23 quarters since. The position peaked at $284K in Q1 2025. 132 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • CX Institutional held 2,999 shares of Zimmer Biomet worth $258K as of Q2 2026.
  • CX Institutional bought 1,825 Zimmer Biomet shares in Q2 2026, an estimated $160K.
  • Zimmer Biomet made up 0.01% of CX Institutional's portfolio in Q2 2026, its #680 holding.
  • CX Institutional first reported a position in Zimmer Biomet in Q1 2019 and has held it in 23 quarters since.
  • CX Institutional's Zimmer Biomet position peaked at $284K in Q1 2025.
  • 132 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.